Alflutop injection solution ampoules 2ml N5
Condition: New product
993 Items
Rating:
Be the first to write a review!
More info
Active ingredients
bioactive concentrate from small sea fish
Release form
Solution
Composition
on 1 ml: Active substances: Bioactive concentrate from small sea fish - 0.1 ml, Sprat (Sprattus sprattus sprattus), Black Sea Merlang (Odontogadus merlangus euxinus), Black Sea Alosa (tanaica nordmanni), Black Sea Anchovy (Engraulus ecologus ecologic ecologicus) Excipients: water for injection (up to 1 ml), phenol (max. 0.005 g).
Pharmacological effect
Alflutop - chondroprotector, the active component of which is a bioactive concentrate from small marine fish, obtained by extraction with subsequent deproteinization and delipidization. The concentrate contains mucopolysaccharides (chondroitin sulfate), amino acids, peptides, ions of sodium, potassium, calcium, magnesium, iron, copper and zinc. Alflutop prevents the destruction of the macromolecular structures of normal tissues, stimulates recovery processes in the interstitial tissue and articular cartilage tissue, which explains its anesthetic action. Anti-inflammatory action and tissue regeneration are based on the inhibition of hyaluronidase activity and normalization of hyaluronic acid biosynthesis. Both of these effects are synergistic and determine the activation of regenerative processes in tissues (in particular, the restoration of cartilage structure).
Indications
Primary and secondary osteoarthritis of various localization (coxarthrosis, gonarthrosis, arthrosis of small joints); spondylosis; osteochondrosis.
Contraindications
Hypersensitivity to the components of the drug, pregnancy, lactation, childhood and adolescence (due to the lack of data from clinical studies in this category of patients).
Use during pregnancy and lactation
The drug is contraindicated for use during pregnancy and lactation.
Dosage and administration
In case of polyosteoarthrosis and osteochondrosis, Alflutop solution is injected deep intramuscularly, 1 ml per day. The course of treatment is 20 injections (1 injection per day for 20 days). In the case of predominant lesions of large joints, the drug is injected into the joint 1-2 ml into each joint with an interval of 3-4 days between injections. The course of treatment is 5-6 injections into each joint. A combination of intramuscular injection and intra-articular injection is possible. The course of treatment should be repeated after 6 months.
Side effects
Rarely: pruritic dermatitis, reddening of the skin, burning sensation at the injection site, short-term myalgias. Very rare: anaphylactic reactions. In some cases: transient increase in pain (with intra-articular administration).
Overdose
Symptoms: In susceptible patients, allergic reactions may occur, sometimes severe. Treatment: drug withdrawal, symptomatic therapy.
special instructions
In case of individual intolerance to seafood (sea fish), the risk of allergic reactions increases.